Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Eargo Inc.
During Q2, biopharmas brought in an aggregate $12.5bn in financing and device company fundraising totaled $3.7bn; while in vitro diagnostic firms and research tools players raised $720m.
The company, which denies the allegations, allegedly sold hearing aids to federal employees and billed a government insurance plan without the required hearing assessment.
From innovation to legislation, the US audiology market is being shaped by cutting-edge technology from device makers and legislation from the Biden administration to get more hearing aids to those that need them.
Directly billing insurers for OTC hearing aids may have triggered federal concern, a financial analysis firm says.
- Rehabilitation Equipment and Devices